Overview

Maintenance Hormonal Therapy and DLBCL

Status:
NOT_YET_RECRUITING

Trial end date:
2029-03-01

Target enrollment:

Participant gender:

Summary

the study aims to detect the benefit of maintenance tamoxifen after achieving CR with conventional immuno-chemotherapy and/or radiotherapy in patients with DLDCL

Phase:

PHASE2

Details

Lead Sponsor:

Sohag University

Treatments:

Tamoxifen